[기업분석 레포트] KTB투자증권, 아직 대기 수요가 많은 올리고 CMO — ST PHARM

Science & Technology
- Business Overview사업영역
- CDMO위탁생산개발
- CRO위탁임상서비스
  - AnaPath Research & Service
- R&D연구개발
  - Virtual R&D
  - Global R&D
About
Public
- PR (Public Relations)
  - News room
- IR (Investor Relations)
  - Stock Information
  - IR Library
Careers
ESG

Linkedin

Public

IR Materials

PR (Public Relations)
- News room
IR (Investor Relations)
- Stock Information
- IR Library

IR Materials

Sep 2, 2020

[기업분석 레포트] KTB투자증권, 아직 대기 수요가 많은 올리고 CMO

- 투자의견 : CMO 기업중 추천

- 목표주가 : Not Rating

KTB투자증권_에스티팜_20200902081630.pdf